• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinicians' Intention to Submit Microbiological Pathogenic Test Before Antibiotics Use and Its Influencing Factors: New Evidence from the Perspective of Hospital Management.临床医生在使用抗生素前提交微生物病原学检测的意愿及其影响因素:来自医院管理视角的新证据
Infect Drug Resist. 2022 Jun 11;15:3013-3023. doi: 10.2147/IDR.S366892. eCollection 2022.
2
Factors Influencing Clinicians' Use of Hospital Information Systems for Infection Prevention and Control: Cross-Sectional Study Based on the Extended DeLone and McLean Model.影响临床医生使用医院信息系统进行感染预防和控制的因素:基于扩展的德洛恩和麦克莱恩模型的横断面研究。
J Med Internet Res. 2023 Jun 22;25:e44900. doi: 10.2196/44900.
3
The Sample Error Pre-Antimicrobial Susceptibility Testing and Its Influencing Factors from the Perspective of Hospital Management: A Cross-Sectional Study.从医院管理角度看抗菌药物敏感性试验前的样本误差及其影响因素:一项横断面研究
Antibiotics (Basel). 2022 Nov 28;11(12):1715. doi: 10.3390/antibiotics11121715.
4
Effect analysis of multi-department cooperation in improving etiological submission rates before antibiotic treatment.多部门合作提高抗生素治疗前病因送检率的效果分析。
Int J Qual Health Care. 2023 Jun 6;35(2). doi: 10.1093/intqhc/mzad018.
5
The pre-analytical process management status and influencing factors of laboratory test before prescribing antimicrobial in developing country.发展中国家处方前抗菌药物检验前过程管理现状及影响因素
BMC Health Serv Res. 2023 Mar 25;23(1):283. doi: 10.1186/s12913-023-09243-8.
6
Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework.理解 ICU 中抗生素处方决策:必要性关注框架的应用。
BMJ Qual Saf. 2022 Mar;31(3):199-210. doi: 10.1136/bmjqs-2020-012479. Epub 2021 Jun 7.
7
Can targeted interventions change the factors influencing variation in management of infants with bronchiolitis? A survey of Australian and New Zealand clinicians: A paediatric research in emergency departments international collaborative (PREDICT) study.针对干预能否改变影响毛细支气管炎患儿管理差异的因素?对澳大利亚和新西兰临床医生的调查:儿科急症研究国际协作组织(PREDICT)研究。
J Paediatr Child Health. 2022 Feb;58(2):302-311. doi: 10.1111/jpc.15710. Epub 2021 Sep 9.
8
Thai clinicians' attitudes toward antimicrobial stewardship programs.泰国临床医生对抗菌药物管理计划的态度。
Am J Infect Control. 2018 Apr;46(4):425-430. doi: 10.1016/j.ajic.2017.09.022. Epub 2017 Nov 10.
9
Patients' and Clinicians' Perceptions of Antibiotic Prescribing for Upper Respiratory Infections in the Acute Care Setting.患者和临床医生对上呼吸道感染在急性护理环境中抗生素处方的看法。
Med Decis Making. 2018 Jul;38(5):547-561. doi: 10.1177/0272989X18770664.
10
Clinicians' perceptions of the problem of antimicrobial resistance in health care facilities.临床医生对医疗机构中抗菌药物耐药性问题的看法。
Arch Intern Med. 2004;164(15):1662-8. doi: 10.1001/archinte.164.15.1662.

引用本文的文献

1
Improving Antimicrobial Utilization and Infection Control in Ophthalmology: An Information-Assisted Transparent Supervision and Multidisciplinary Team Model.改善眼科抗菌药物使用与感染控制:一种信息辅助的透明监督与多学科团队模式
Infect Drug Resist. 2024 Nov 13;17:5061-5072. doi: 10.2147/IDR.S481050. eCollection 2024.

本文引用的文献

1
BmpA-BBK32 and BmpA-BBA64: New Recombinant Chimeric Proteins with Potential Diagnostic Value.BmpA-BBK32和BmpA-BBA64:具有潜在诊断价值的新型重组嵌合蛋白。
Pathogens. 2021 Jun 18;10(6):767. doi: 10.3390/pathogens10060767.
2
Restricted antimicrobial prescribing in an area of highly prevalent antimicrobial resistance.在高度流行抗菌素耐药的地区限制使用抗菌素。
Infect Dis Now. 2021 Sep;51(6):526-531. doi: 10.1016/j.idnow.2021.05.002. Epub 2021 May 12.
3
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.一项观察性队列研究,探讨了在英国伦敦西北部医院因 COVID-19 就诊的患者中细菌合并感染的情况及其对经验性抗生素治疗的影响。
J Antimicrob Chemother. 2021 Feb 11;76(3):796-803. doi: 10.1093/jac/dkaa475.
4
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.在荷兰的一项多中心回顾性队列研究中,COVID-19 住院患者早期的细菌合并感染较少,但经验性抗生素使用频繁。
Infect Dis (Lond). 2021 Feb;53(2):102-110. doi: 10.1080/23744235.2020.1839672. Epub 2020 Oct 24.
5
Use of stewardship smartphone applications by physicians and prescribing of antimicrobials in hospitals: A systematic review.医生使用管理智能手机应用程序和医院开处抗菌药物:系统评价。
PLoS One. 2020 Sep 29;15(9):e0239751. doi: 10.1371/journal.pone.0239751. eCollection 2020.
6
Understanding the role of bacterial and fungal infection in COVID-19.了解细菌和真菌感染在新冠病毒病中的作用。
Clin Microbiol Infect. 2021 Jan;27(1):9-11. doi: 10.1016/j.cmi.2020.09.025. Epub 2020 Oct 9.
7
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染:一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
8
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染:系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
9
Policy document on antimicrobial stewardship practices in India.印度抗菌药物管理政策文件。
Indian J Med Res. 2019 Feb;149(2):180-184. doi: 10.4103/ijmr.IJMR_147_18.
10
Rapid detection of low-level HeLa cell contamination in cell culture using nested PCR.使用巢式 PCR 快速检测细胞培养物中低水平的 HeLa 细胞污染。
J Cell Mol Med. 2019 Jan;23(1):227-236. doi: 10.1111/jcmm.13923. Epub 2018 Oct 24.

临床医生在使用抗生素前提交微生物病原学检测的意愿及其影响因素:来自医院管理视角的新证据

Clinicians' Intention to Submit Microbiological Pathogenic Test Before Antibiotics Use and Its Influencing Factors: New Evidence from the Perspective of Hospital Management.

作者信息

Wang Qianning, Zhang Xinping, Zheng Feiyang, Wang Lu, Yu Tiantian

机构信息

School of Medicine and Health Management, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.

出版信息

Infect Drug Resist. 2022 Jun 11;15:3013-3023. doi: 10.2147/IDR.S366892. eCollection 2022.

DOI:10.2147/IDR.S366892
PMID:35720253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9199522/
Abstract

PURPOSE

Antimicrobial resistance (AR) is a global public health problem, improving clinicians' intention to submit microbiological pathogenic test (submission intention) can effectively increase the value for rational use antibiotics to curb AR. However, there are few studies on the factors influencing improvement of the submission intention, especially from the perspective of hospital management. This study will fill the gap and provide evidence that can continuously support improvement of antibiotics prescribing rationally.

PATIENTS AND METHODS

A cross-sectional survey of clinicians was conducted in all public hospitals in Hubei, China. Dependent variables were submission intention of non-restricted-use, restricted-use and special-use antibiotics which were measured submission, not sure submission, no submission. Independent variables were frequency of training and publicity on submission, and hospital with or without submission performance assessment, guideline, information decision system and laboratory items, including bacterial culture item, fungal culture item and so on. Clinicians' demographics were applied as control variables. Multinomial logistic regression was performed to model independent variables influencing submission intention.

RESULTS

For non-restricted-use antibiotics, guideline (OR = 0.263; 95% CI = [0.188, 0.369]) (OR = 0.526; 95% CI = [0.375, 0.738]) and bacterial culture item (OR = 0.141; 95% CI = [0.074, 0.268]) (OR = 0.520; 95% CI = [0.292, 0.927]) are key factors that positively affect clinicians' intention on submission and not sure submission; For restricted-use and special-use antibiotics, training frequency and bacterial culture item (OR = 0.155; 95% CI = [0.076, 0.315]) (OR = 0.092; 95% CI = [0.036, 0.232]) (OR = 0.106; 95% CI = [0.046, 0.248]) (OR = 0.027; 95% CI = [0.006, 0.117]) are key factors that positively affect clinicians' intention on submission and not sure submission.

CONCLUSION

This study found that bacterial culture item, guideline, and training frequency are key factors that affect clinicians' intention on submission and not sure submission, but various factors exist different effects level on different types of antibiotics. Consequently, a focus should be placed on the construction and implementation of management factors, as well as reformation of antimicrobial stewardship in hospitals according to the types of antibiotics.

摘要

目的

抗菌药物耐药性是一个全球性的公共卫生问题,提高临床医生提交微生物病原学检测的意愿(提交意愿)能够有效增加合理使用抗生素的价值,从而遏制抗菌药物耐药性。然而,关于影响提交意愿改善因素的研究较少,尤其是从医院管理角度。本研究将填补这一空白,并提供能够持续支持合理使用抗生素的证据。

患者与方法

对中国湖北省所有公立医院的临床医生进行了横断面调查。因变量为非限制使用、限制使用和特殊使用抗菌药物的提交意愿,分为提交、不确定是否提交、不提交。自变量为提交相关的培训和宣传频率,以及医院是否有提交绩效评估、指南、信息决策系统和实验室项目,包括细菌培养项目、真菌培养项目等。临床医生的人口统计学特征作为控制变量。采用多项逻辑回归对影响提交意愿的自变量进行建模。

结果

对于非限制使用抗菌药物,指南(比值比[OR]=0.263;95%置信区间[CI]=[0.188,0.369])(OR=0.526;95%CI=[0.375,0.738])和细菌培养项目(OR=0.141;95%CI=[0.074,0.268])(OR=0.520;95%CI=[0.292,0.927])是积极影响临床医生提交意愿和不确定是否提交意愿的关键因素;对于限制使用和特殊使用抗菌药物,培训频率和细菌培养项目(OR=0.155;95%CI=[0.076,0.315])(OR=0.092;95%CI=[0.036,0.232])(OR=0.106;95%CI=[0.046,0.248])(OR=0.027;95%CI=[0.006,0.117])是积极影响临床医生提交意愿和不确定是否提交意愿的关键因素。

结论

本研究发现细菌培养项目、指南和培训频率是影响临床医生提交意愿和不确定是否提交意愿的关键因素,但不同因素对不同类型抗菌药物的影响程度不同。因此,应注重管理因素的构建与实施,并根据抗菌药物类型对医院抗菌药物管理进行改革。